Skip to content
10-Q

Quarterly Report

Gala Pharmaceutical Inc.

0001683168-18-002092

← back to feed
Filed
Aug 1, 2018 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2018 · Jul 25, 2018 57.2M sh
Cash And Equivalents Q2 2018 · May 31, 2018 $39.18K
Cash And Equivalents Q2 2018 · Nov 30, 2017 $7.77K
Cash And Equivalents Q2 2018 · May 31, 2017 $0
Cash And Equivalents Q2 2018 · Nov 30, 2016 $10.84K
Stockholders Equity Q2 2018 · May 31, 2018 −$697.48K
Stockholders Equity Q2 2018 · Nov 30, 2017 −$905.82K
Total Liabilities Q2 2018 · May 31, 2018 $967.46K
Total Liabilities Q2 2018 · Nov 30, 2017 $1.01M
Current Assets Q2 2018 · May 31, 2018 $224.95K
Current Assets Q2 2018 · Nov 30, 2017 $61.92K
Total Assets Q2 2018 · May 31, 2018 $265.56K
Total Assets Q2 2018 · Nov 30, 2017 $107.98K
Operating Cash Flow Q2 2018 · May 31, 2017 −$39.66K
Sga Expense Q2 2018 · May 31, 2017 $14.6K
Sga Expense Q2 2018 · May 31, 2017 $25.25K
Net Income Q2 2018 · May 31, 2017 −$373.1K
Net Income Q2 2018 · May 31, 2017 −$404.47K
Gross Profit Q2 2018 · May 31, 2017 $0
Gross Profit Q2 2018 · May 31, 2017 $0
Cost Of Revenue Q2 2018 · May 31, 2017 $0
Cost Of Revenue Q2 2018 · May 31, 2017 $0
Revenue Q2 2018 · May 31, 2017 $0
Revenue Q2 2018 · May 31, 2017 $0